Brief: Dice Therapeutics Reports Q1 Loss Per Share Of $0.50
May 12 (Reuters) - Dice Therapeutics Inc DICE.O :
* DICE THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
* DICE THERAPEUTICS INC - QTRLY NET LOSS TOTALED $18.6
MILLION
* DICE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.50
* DICE THERAPEUTICS INC - CURRENT CASH PROVIDES RUNWAY
THROUGH
MID-2024
Further company coverage: DICE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dice Therapeutics
See all newsBrief: Lilly Completes Acquisition Of Dice Therapeutics
Dice Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Eli Lilly Announces Extension Of Tender Offer To Acquire Dice
MoonLake Immunotherapeutics explores sale-sources
MoonLake Immunotherapeutics explores sale-sources